Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FRTX | Common Stock | Options Exercise | +55K | +1078.01% | 60.1K | Oct 2, 2023 | Direct | F1, F2, F3, F4 | ||
transaction | FRTX | Common Stock | Tax liability | -$20.4K | -20.8K | -34.66% | $0.98 | 39.3K | Oct 2, 2023 | Direct | F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FRTX | Restricted Stock Units | Options Exercise | $0 | -55K | -100% | $0.00* | 0 | Oct 2, 2023 | Common Stock | 55K | Direct | F2, F6 |
Andrew Sklawer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | The restricted stock units were granted on January 24, 2023 and were subject to accelerated vesting as of the date of the reporting person's termination pursuant to his employment agreement with the issuer. |
F2 | Each restricted stock unit converted into common stock on a one-for-one basis. |
F3 | On July 5, 2022, the registrant effected a 1-for-45 reverse stock split ("Reverse Stock Split") of its common stock. The number of shares beneficially owned has been adjusted to give effect to the Reverse Stock Split. |
F4 | This balance includes 2,333 shares purchased under the Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan that were not previously reported. |
F5 | Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units. |
F6 | The restricted stock units vested in full on October 2, 2023. |